ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Bioprostheses With a New Tissue Treatment Platform (COMMENCE) (COMMENCE)
ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Aortic and Mitral Bioprostheses (Models 11000A and 11000M) With a New Tissue Treatment Platform (COMMENCE)
Sponsor: Edwards Lifesciences
A NA clinical study on Aortic Stenosis and Aortic Valve Insufficiency, this trial is ongoing. The trial is conducted by Edwards Lifesciences and has accumulated 20 data snapshots since 2012. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
20 versions recorded-
Dec 2025 — Present [monthly]
Active Not Recruiting NA
-
Sep 2025 — Dec 2025 [monthly]
Active Not Recruiting NA
-
Feb 2025 — Sep 2025 [monthly]
Active Not Recruiting NA
-
Sep 2024 — Feb 2025 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
▶ Show 15 earlier versions
-
Feb 2024 — Jul 2024 [monthly]
Active Not Recruiting NA
-
Feb 2023 — Feb 2024 [monthly]
Active Not Recruiting NA
-
Feb 2022 — Feb 2023 [monthly]
Active Not Recruiting NA
-
Feb 2021 — Feb 2022 [monthly]
Active Not Recruiting NA
-
Jan 2021 — Feb 2021 [monthly]
Active Not Recruiting NA
-
Mar 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
-
Feb 2020 — Mar 2020 [monthly]
Active Not Recruiting NA
-
Jan 2020 — Feb 2020 [monthly]
Active Not Recruiting NA
-
Sep 2019 — Jan 2020 [monthly]
Active Not Recruiting NA
-
Oct 2018 — Sep 2019 [monthly]
Active Not Recruiting NA
-
Aug 2018 — Oct 2018 [monthly]
Active Not Recruiting NA
-
Jun 2018 — Aug 2018 [monthly]
Active Not Recruiting NA
-
Sep 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
-
Feb 2017 — Sep 2017 [monthly]
Active Not Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting NA
First recorded
Dec 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Edwards Lifesciences
For direct contact, visit the study record on ClinicalTrials.gov .